Avian Influenza JUNE Lab Report: Scientific Developments In The Fight Against H5N1

JPD

Inactive
Chinese scientist urges improvement of bird flu control methods

http://english.peopledaily.com.cn/200606/06/eng20060606_271327.html

The Chinese government should review the strategies and effects of the bird flu control efforts of the past two years and improve them to cope with the epidemic which is still a serious threat, said a Chinese scientist in Beijing on Monday.

"When, and to what extent, the current avian influenza virus could evolve into a human pandemic is unpredictable. We should do our best to reduce the risk of a human pandemic influenza breaking out and make necessary preparations before such a risk becomes reality," said Chinese bird flu control expert Liu Xiufan.

Liu, a member of the Chinese Academy of Engineering (CAE), said at a national conference of the CAE members that controlling the H5N1 virus in poultry at its source is the best way to reduce or even eliminate the risk of a human pandemic virus.

He said the full range of control measures should include enforced biosecurity of poultry farms and restriction on the movement of poultry and products, culling of infected poultry, quarantine, disinfection, and prudent use of vaccines.

]Some changes in the H5N1 virus have taken place recently. The virus has increased virulence to ducks, and the currently available vaccines are not effective for protecting poultry, said Liu.

The H5N1 viruses isolated during the 2004-2006 period have increased their ability to replicate in mammalian cell culture. The transmission mode of the viruses is changing from fecal-oral to aerosol, said the scientist, adding that the viruses have increased resistance to the environment, especially to temperature.


He noted that it is a big challenge for China to eradicate the H5N1 viruses because the viruses have been circulating in poultry in China for some time.

The outbreaks of bird flu have affected vast areas of China. The extensive presence of waterfowls and vaccinated birds as the carriers of the H5N1 virus has increased the difficulty of effective control and eradication, Liu said.

China produces 3.7 billion waterfowls each year, more than 75 percent of the world's total.

Huge numbers of small poultry holders scattered all over China increase the difficulty of disease prevention and control, Liu added.

The government should sponsor a review of the strategy and its implementation and to evaluate the effectiveness of the prevention and control of bird flu in the last two years, Liu said.

Because bird flu infection has become endemic in some areas in China and cannot be stamped out in a short time, the government should draw up a short-term plan of prevention and control and a long-term program of eradication, Liu added.

More than 80 outbreaks of bird flu have been reported in China since February 2004, affecting 24 provinces, municipalities and autonomous regions. Eighteen confirmed human cases with 12 fatalities have been reported since last September.

Source: Xinhua
 

PCViking

Lutefisk Survivor
H5N1 Signature May Help Detection

by Kate Walker
Oxford, England (UPI) Jun 08, 2006

Biotechnology research and development company BioWarn LLC this week announced that its SmartSense biological substance detection system can instantly detect the presence of the H5N1 subtype of avian influenza.
"Using SmartSense, an outbreak of human avian flu can be detected and isolated in its early stages so that prevention, vaccines, and treatment can immediately be administered," said Dr. James P. Wade Jr., chairman of the board and chief executive officer of BioWarn.

BioWarn President and Chief Operating Officer Dr. Jeffrey Riggs said: "While current techniques require additional processing, SmartSense detection is direct, positive, and binary, providing a real-time indication of the presence of a virus such as avian flu on a molecular level. The SmartSense system instantaneously detects unique interaction signatures with extremely high reliability, and then wirelessly transmits the information to the necessary officials."

SmartSense -- which also detects HIV, tuberculosis, MRSA, E.coli, anthrax and smallpox, among others -- works by capturing the electronic signature of a virus or biological agent, which it then instantly recognizes. Once SmartSense has identified the presence of a virus, those operating the system are alerted.

It is hoped that such a detection system will be a boon in identifying carriers of avian influenza and may help stem the spread of a human pandemic should one occur.


Source: United Press International

http://www.terradaily.com/reports/H5N1_Signature_May_Help_Detection.html

:vik:
 

PCViking

Lutefisk Survivor
Posted on Wed, Jun. 21, 2006

Tyson chicken lab busy screening for avian flu

MONTE MITCHELL
Winston-Salem Journal

WILKESBORO, N.C. - Small vials of chicken-blood serum arrive by the thousands each week in FedEx and UPS deliveries to a brick building along N.C. 268.

Seven days a week, workers at the Tyson Foods laboratory conduct screening tests for avian influenza.

There are many types of bird flu, but the issue is getting worldwide attention because of a particular strain, the Asian avian influenza A (H5N1). The World Health Organization says that this strain of the Asian bird flu has killed 129 people since 2003, mostly in Indonesia and Vietnam.

This type of flu has never been detected in North America. According to the Centers for Disease Control and Prevention, the spread of the disease from person to person is rare. Properly cooked chicken is safe to eat, even if it came from an infected bird.

The disease has spread to parts of Europe and Africa, and continues to pose an important and growing public health threat, the CDC says.

Tyson, as other poultry companies, has increased its testing for bird flu.

Every Tyson flock is tested before it leaves the farm. A negative test for avian influenza is required before the chickens can be loaded onto a truck for a trip to the processing plant. A flock would be destroyed and other biomedical safety steps taken if bird flu were ever found.

Tyson conducts 15,000 tests a week for avian influenza, about five times the number the company was conducting a year ago.
Most of the companywide testing is done at the Wilkesboro lab already, and the lab will soon do all the company's bird-flu testing for processing operations in 12 states.

"We were doing it before it was popular," said Leonard Brooks, the supervisor for the serology lab, talking about how Tyson has been testing for bird flu for decades. He has worked in the Wilkesboro lab for 40 years, with Holly Farms and then with Tyson. "We did a lot of this stuff before anybody ever thought about it," he said.

A bird-flu outbreak has never been associated with the Tyson Foods complex in Wilkesboro, but public perception is especially important in a county whose plant produces more pounds of chicken meat than any other Tyson processing plant in the nation. Tyson is the biggest employer in Wilkes County. The 91 million broiler chickens grown in Wilkes in 2004 made it the top county in North Carolina for broilers, according to the most recent statewide statistics released by the N.C. Department of Agriculture.

The increased company tests are one step in a line of defense designed to protect people and the chicken supply.

The state agriculture department also has an extensive program that has tested more than 200,000 birds from state poultry flocks in the past year.

Earlier this year, Tyson joined other chicken companies in a comprehensive testing program, announced by the National Chicken Council, the industry's trade association. The companies use procedures approved by the National Poultry Improvement Plan, a federal and state cooperative program. Because of the increased emphasis on the testing, Tyson has renovated a storage room to create more lab space for the avian-influenza tests.

The enclosed, climate-controlled chicken houses of Wilkes and surrounding counties represent a big difference in how chickens are raised, compared to the areas where the Asian bird-flu outbreaks have occurred. For instance, it's not uncommon for chickens in Asia to live closely with humans, wandering through a family's living areas.

Tyson growers here have bio-security measures in place - for example, they step into disinfectant baths before entering the house. They are also required to limit who enters a farm.

Chicken houses vary in size, but it's not unusual for a single broiler house to have 6,000 chickens that live together six to eight weeks. The flocks are raised together in "all-in, all-out" farming, isolating a particular flock to limit its exposure to outside birds and make it possible to trace a flock back to a farm.

Within 10 days of an anticipated slaughter date for the broilers, a service worker will go into the mass of squawking chickens in each house. The worker picks out several birds. In each, he'll do a wing stab to puncture a wing vein and collect two to three cubic centimeters of blood.

Because the bird-flu virus would move rapidly through a flock, a sample of birds is sufficient to see if any of the birds have been exposed to the virus.


Tyson workers deliver local samples to the Wilkesboro lab, which has an advanced international accreditation that requires audits and constant checks.

"Because of that, we have a tremendous quality standard in place," said Beverly Prevette, an associate chemist.

Samples from locally raised birds arrive in vials of whole blood. The vials that are shipped in from other regions contain only blood serum, a yellowish fluid that is separated from a blood clot after coagulation.

Lab workers conduct a basic scientific procedure called the Agar Gel Immunodiffusion Test to check for antibodies that would be produced in the presence of the virus. The test uses petri dishes filled with a clear gel. Workers use a manual hole-punch machine to create seven clusters of seven small wells in the gel. The middle well in each cluster holds an antigen - that's the substance a body reacts to by producing antibodies. A worker uses a pipette to put blood-serum samples into three of the surrounding wells, and the other three wells are filled with positive reference samples.

With three blood samples going into each of the seven clusters, each petri dish can test 21 birds. Each petri dish is labeled with the flock information, and then stored. The liquid from the samples diffuses through the gel. After 24 hours, a lab worker takes the petri dish into a darkened room and looks at it under a high-intensity light.

The worker looks for a thin white line that would appear if the antibodies try to link up to fight the virus. If workers ever do find a positive test, written instructions tell them who to call and what steps to take. The lab is screening for bird flu, and would send the sample to another lab for tests to determine the specific strain of flu

"We've already got procedures in place, what to do, sort of like a fire drill," said Chy Billings II, whose duties include being the lab's safety officer.

The lab building contains many testing rooms for other things besides bird flu. The more than 30 lab workers test chickens for pesticides, they test feed to make sure it provides adequate nutrition, and they analyze meat products being shipped to fast-food restaurants. The lab regularly monitors and tests breeder birds, checking to make sure they pass on maternal antibodies to chicks.

"We found out many years ago that preventative medicine is much better than curative medicine," Brooks said.

http://www.charlotte.com/mld/observer/news/local/14868820.htm

:vik:
 

PCViking

Lutefisk Survivor
Public release date: 21-Jun-2006

Scientists aim to thwart use of flu as bioweapon

Flu is already a big killer, responsible for more than 35,000 deaths in the United States alone each year. And wild birds infected with the deadly H5N1 strain of bird flu are gradually broadening the scope of that disease. This week in Rochester, scientists are discussing ways to better understand the flu and also how to prevent the possibility that terrorists could somehow modify flu as a bioweapon to make it even more lethal than it is already.

Among the highlights of this week's two-day symposium, hosted by the University of Rochester Center for Biodefense Immune Modeling, is a lecture by Nobel Prize winner Peter Doherty, Ph.D., an expert on how flu spurs the immune system to defend itself against the infection. Doherty's technical talk on the roles of specific types of T-cells in influenza will be at 1:30 p.m. Friday, June 23, at the Rochester Marriott Airport Hotel on West Ridge Road. The lecture is free and open to the public.

During the symposium Thursday and Friday, University of Rochester experts in mathematics, statistics, immunology, and infectious diseases will join with colleagues from around the nation to discuss exactly how flu invades the body, how the body responds, and how mathematicians, statisticians, and computer scientists are working to help understand the pathogenesis of flu infection. The group will also talk about the potential of flu to be intentionally modified for use as a lethal weapon more deadly than bird flu, and ways to prevent that from happening.

"Flu viruses are deadly – witness the 1918 Spanish flu which killed millions of people – and with modification, they can be made even more deadly," said Hulin Wu, Ph.D., professor in the Department of Biostatistics and Computational Biology and director of the modeling center. Wu's colleague, Martin Zand, M.D., Ph.D., co-director of the center, added that "We don't know whether flu will be weaponized; it's crucial to ask the question and to be prepared."

The focus of Wu's center, funded by the National Institutes of Health, is the mathematical modeling of infectious diseases. When the flu virus infects the body, for instance, a cascade of complex events occur to fight the virus as it commandeers cells and begins churning out viral particles that attack the body. The immune system falls back on an array of cells, especially antibody-producing B-cells and flu-killing T cells, to fight back. Understanding just how that occurs, and simulating that with computers, is the goal of the center.

Wu points to the improved treatment of HIV as an area where such an approach has already yielded enormous benefit to patients. Once considered a death sentence, HIV infection is now more commonly viewed as a chronic infection thanks largely to improved treatment. Much of the improvement is due to early mathematical models that helped scientists and physicians understand and target the disease more effectively.

"How flu infects the body and how the body responds to a flu infection is not understood completely," said Wu. "Mathematical models will help guide flu experts to ask the right questions, so that we understand it more thoroughly than we do today. Understanding exactly what is happening should help scientists evaluate how the virus will respond to drugs designed to treat an infection."

Since flu is already a killer, the discussions will have an immediate application among scientists looking for ways to stop or better treat "natural" flu. The work also helps scientists like John Treanor, M.D., and David Topham, Ph.D., who are designing and testing new vaccines designed to prevent all types of flu, including bird flu. The University is recognized internationally as a leader in the testing of bird-flu vaccines.

"For many years people did not recognize the importance of flu research," said Topham, associate professor of Microbiology and Immunology and a scientist in the David H. Smith Center for Vaccine Biology and Immunology. "Flu research was seen as humdrum and routine, and there was no driving force to do that research. It just sort of blended into the background. People assumed that since there is a vaccine, it wasn't a disease of interest any more.

"But with bird flu on the horizon and the vaccine shortages that have occurred in recent years, it's become a hotbed of research interest. Besides, flu is responsible for 35,000 deaths and 200,000 hospitalizations in the United States alone. It's a serious health problem," Topham added.


###

http://www.eurekalert.org/pub_releases/2006-06/uorm-sat062106.php
 

PCViking

Lutefisk Survivor
Another milestone: WHO has concluded that human-to-human transmission likely

WHO: Bird flu spread among family members

By MARGIE MASON, AP Medical WriterWed Jun 21, 4:50 PM ET

The World Health Organization has concluded that human-to-human transmission likely occurred among seven relatives who developed bird flu in Indonesia.

In a report obtained Wednesday by The Associated Press, WHO experts said the cluster's index case was probably infected by sick birds and spread the disease to six family members. One of those cases, a boy, then likely infected his father, it said.

The U.N. agency stressed the virus has not mutated and that no cases were detected beyond the family.

Seven of the eight relatives died last month, but one was buried before samples could be taken to confirm bird flu infection.

"Six confirmed H5N1 cases likely acquired (the) H5N1 virus through human-to-human transmission from the index case ... during close prolonged contact with her during the late stages of her illness,"
the report said.

The report was distributed at a closed meeting in Jakarta attended by some of the world's top bird flu experts. The three-day session was convened after Indonesia asked for international help. The country has recorded the world's highest number of human bird flu cases this year, and 39 of those infected have died.

"What is happening in Indonesia? That is the No. 1 question," said Bayu Krishnamurthi, Indonesia's national bird flu coordinator. "With all of these limited resources — human, financial, institutional — what should we do?"

The experts were expected to discuss the large family cluster during the session. One of the remaining mysteries is why only blood relatives — not spouses — became infected.

The WHO report theorizes the family shared a "common genetic predisposition to infection with H5N1 virus with severe and fatal outcomes." However, there is no evidence to support that.

Keiji Fukuda, WHO's coordinator for the Global Influenza Program in Geneva, said the Indonesian case appears to resemble other family clusters where limited human-to-human transmission occurred following close contact. He said scientists must find out whether anything is different about the way the virus is behaving.

"The really critical factor is why did that cluster develop?" he said. "What's the reason why people in a cluster got infected?"

Fukuda said that although the cluster in the farming village on Sumatra island grabbed world attention, no country — including Vietnam and Thailand, which have largely controlled the virus — is safe from bird flu.

"This is a virus that you both have to respect a lot and (you) have to be concerned about the overall situation, even in areas in which it looks like control has been achieved," he said on the meeting's sidelines. "The real question is: Can you sustain that control for a virus which is really able to persist this way?"

Bird flu has killed at least 130 people worldwide since it began ravaging Asian poultry stocks in late 2003. Experts fear the virus will mutate into a form that spreads easily among people, potentially sparking a pandemic. So far, it remains hard for people to catch, and most human cases have been traced to contact with infected birds.

Indonesian officials said the country lacks manpower and money to battle the H5N1 virus alone. The government has been saddled with a series of natural disasters, including the 2004 tsunami and an earthquake last month on Java Island.

Indonesia needs $50 million from donors in the next three years to establish a system to help fight bird flu in poultry, according to Peter Roeder of the U.N. Food and Agriculture Organization.

Indonesia has said it needs $900 million over the next three years for its overall battle against the H5N1 virus but has only budgeted $59 million.

___

http://news.yahoo.com/s/ap/indonesi...5KTvyIi;_ylu=X3oDMTBiMW04NW9mBHNlYwMlJVRPUCUl

:vik:
 

PCViking

Lutefisk Survivor
Another milestone: WHO has concluded that virus has mutated

WHO says H5N1 virus mutated slightly in Indonesian family

MARGIE MASON

Associated Press

JAKARTA — A World Health Organization investigation showed that the H5N1 virus mutated slightly in an Indonesian family cluster on Sumatra island, but bird flu experts insisted Friday it did not increase the possibility of a human pandemic.

The virus that infected eight members of a family last month — killing seven of them — appears to have slightly mutated in a 10-year-old boy, who is then suspected of passing the virus to his father, the WHO investigative report said.

It is the first evidence of possible human-to-human-to-human transmission of the H5N1 virus, said Tim Uyeki, an epidemiologist from the U.S. Centers for Disease Control and Prevention, adding that the virus died with the father and did not pass outside the family.

“It stopped. It was dead end at that point,”
he said, stressing that viruses are always slightly changing and there was no reason to raise alarm bells.

The findings appeared in a report obtained by The Associated Press that was distributed at a closed meeting in Jakarta attended by some of the world's top bird flu experts.

The three-day session that wraps up Friday was convened after Indonesia — which is on pace to become the world's hardest hit nation with 39 human bird flu deaths — asked for international help.

Experts fear the virus will mutate into a form that spreads easily among people, potentially sparking a pandemic. So far, it remains hard for people to catch, and most human cases have been traced to contact with infected birds.

WHO concluded in its report that human-to-human transmission likely occurred among seven relatives infected with the H5N1 virus in a remote farming village on Sumatra island. An eighth family member who was buried before specimens could be taken is believed to have been infected by poultry, a WHO report said.

Despite the virus' slight mutation in the father and son, Mr. Uyeki insisted that an analysis suggested there was “nothing remarkable about these viruses” compared to other human or animal H5N1 viruses.


Bird flu has killed at least 130 people worldwide since it began ravaging Asian poultry stocks in late 2003. Indonesia trails on Vietnam, where 42 people have died, in human bird flu deaths.

http://www.theglobeandmail.com/servlet/story/RTGAM.20060623.windoflu0623/BNStory/International/home

:vik:
 

PCViking

Lutefisk Survivor
Common heart drugs might be bird flu weapon
Statin drugs could turn deadly infection into a milder disease, says doctor

Updated: 4:04 p.m. ET June 21, 2006

WASHINGTON - The world’s top-selling drugs, cholesterol-lowering statins, might provide a way to treat feared bird flu, according to a doctor and retired drug company executive who is trying to get the researchers to study the possibility.

Antivirals that affect the influenza virus are in short supply, and it will be years before vaccine makers can ramp up capacity enough to immunize the world’s population against a pandemic flu.

But what if there was a cheap and widely available drug that helped treat the flu’s worst symptoms and possibly save lives?

Evidence suggests that statin drugs, designed to lower cholesterol, might help turn a potentially deadly infection into a milder disease, according to Dr. David Fedson, who thinks world health authorities ought to take a harder look at the possibility.

“Generic statins are available in virtually every country,” said Fedson, a retired U.S. physician living in France.

“You’ll be able to take five days of statins in India for less than a dollar,” Fedson, who was also director of medical affairs at Aventis Pasteur (now French drug company Sanofi Aventis, said in a telephone interview.

“We have something that conceivably could save tens of thousands of lives. This research is so important that we cannot afford not to take it.”

Fedson, an expert on vaccination, cites several recent studies that show that statins reduce inflammation. Designed to lower cholesterol, the drugs work on several biological processes and may reduce the risk of Alzheimer’s disease, some cancers, and multiple sclerosis.

In January, researchers in Canada reported that statins act against sepsis, a dangerous blood infection and a 2005 study published in the journal Respiratory Research found the death rate was 64 percent lower in pneumonia patients who had been taking statins.

Immune storm
Fedson cites yet other studies that suggest strongly that people who are infected with avian influenza have an immune system overreaction known as a cytokine storm.

Their immune system signals chemicals rush to fight off the alien virus, causing an inflammation of the lungs and other organs that may be what kills them.

“It’s an idea, just an idea and it needs to be substantiated with both cellular-based and animal-based studies,” Fedson said. “We need to do it and we need to do it fast.”

He is getting some attention.

Fedson presented his idea last week to the Congress of Infectious Diseases in Lisbon, Portugal, and is to speak to a bird flu conference next week at the Institut Pasteur in Paris. He also has a paper in next month’s issue of the journal Clinical Infectious Diseases.

Statins — which include Pfizer Inc.’s $10 billion-a-year Lipitor, Bristol-Myers Squibb Co.’s Pravachol and Merck and Co. Inc.’s Zocor — are the world’s best-selling drugs, taken by millions to reduce the risk of heart attack.

Poorly prepared
Experts say a pandemic of some sort of influenza is inevitable.

The H5N1 avian influenza sweeping countries in Asia and also affecting Europe and Africa is considered the most likely candidate. So far it has rarely infected people, but has killed 130 out of 228 infected and just a few mutations would turn it into a form that could be passed easily from one person to another.

If this happens in the next few years, the World Health Organization and other experts agree the world is very poorly prepared and that millions could die.

A WHO spokesman said the agency had no immediate comment on Fedson’s work, and spokespeople for companies that make statins said they had not looked into the possibility of testing the drugs in influenza patients.

http://www.msnbc.msn.com/id/13461236/

:vik:
 

JPD

Inactive
Amantadine Resistance in Karo Cluster in Sumatra Indonesia

http://www.recombinomics.com/News/06250601/H5N1_Karo_Amantadine.html

Recombinomics Commentary
June 25, 2006

The recent meeting on human H5N1 in Indonesia revealed additional detail on the sequences from the Karo cluster and presented several phylogenetic trees representing various genes of the humans isolates.

The H5N1 isolates from the Karo cluster had been described in a prior WHO update. The update had some information on the bird flu sequences of the H5N1 genes from the family members. In the WHO update, the Tamiflu sensitivity of the isolates was noted.

Full genetic sequencing of two viruses isolated from cases in this cluster has been completed by WHO H5 reference laboratories in Hong Kong and the USA. Sequencing of all eight gene segments found no evidence of genetic reassortment with human or pig influenza viruses and no evidence of significant mutations. The viruses showed no mutations associated with resistance to the neuraminidase inhibitors, including oseltamivir (Tamiflu).

The human viruses from this cluster are genetically similar to viruses isolated from poultry in North Sumatra during a previous outbreak.


However, the report failed to mention that all isolates were amantadine resistant. Data at the conference indicated that most of the human isolates in Indonesia were resistant. Prior media reports had indicated that human isolates were sensitive.

In addition, information was presented on the father of the 10 year old nephew of the index case. Media reports had indicated a minor mutation had linked the isolates from the father and son. However, in addition to the minor mutation shared by father and son, the father had 8 additional changes in HA, 3 in NA and 2 in M. These changes suggest that the father had been infected with another flu virus, leading to acquisition of a number of polymorphisms by recombination.

The rapid accumulation of polymorphisms, coupled with amantadine resistance, is cause for concern.

Amantadine resistant isolates:

S31N

A/Indonesia/160H/2005 16F East Jakarta
A/Indonesia/534H/06 18M Karo-North Sumatra
A/Indonesia/535H/06 1.5F Karo-North Sumatra
A/Indonesia/536H/06 29M Karo-North Sumatra
A/Indonesia/538H/06 19M Karo-North Sumatra
A/Indonesia/546H/06 10M Karo-North Sumatra
A/Indonesia/560H/06 35M Karo-North Sumatra

V27A

A/Indonesia/245H/2005 7M East Jakarta
A/Indonesia/286H/2006 4M Indramayu
A/Indonesia/283H/2006 13F Indramayu
A/Indonesia/304H/2006 15M Indramayu
A/Indonesia/292H/06 9F Indramayu
A/Indonesia/239H/2005 39M South Jakarta
A/Indonesia/6H/2005 37F West Jakarta

Amantadine sensitive

A/Indonesia/542H/2005 12M Bekasi-West Java
A/Indonesia/7H/2005 23M Bogor-West Java
A/Indonesia/341H/06 27F Cibinong_West Java
A/Indonesia/321H/06 23M East Jakarta
A/Indonesia/554H/06 18M Kediri-East Jakarta
A/Indonesia/175H/2005 20F North Jakarta
A/Indonesia/298H/2006 22M South Jakarta
A/Indonesia/5/2005 38M Tangerang-Bantan
A/Indonesia/195H/2005 20F Tangerang-Bantan
A/Indonesia/557H/06 39M West Jakarta
 
Top